GlassScriptPhysician profile
Mary Kownack
NPI 1508210667
$1,004.33
in general payments reported to CMS, 2019-2025
19 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $29.14 · 2021: $69.81 · 2022: $58.75 · 2023: $346 · 2024: $165 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716 · Education: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.65 |
| Education | $130.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $207.56 | 2023-2025 | Veozah |
| Amgen INC. | $116.60 | 2025 | Evenity |
| Sumitomo Pharma America, INC. | $99.59 | 2023 | Myfembree |
| Abbvie INC. | $74.59 | 2020-2024 | |
| Stryker Corporation | $69.25 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Organon LLC | $69.23 | 2021-2024 | Nexplanon |
| Myovant Sciences INC. | $66.75 | 2021-2022 | |
| Smith+Nephew, INC. | $56.71 | 2025 | Pico |
| Exeltis, USA INC. | $41.92 | 2024 | Slynd |
| Biogen, INC. | $28.04 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $26.01 | 2025 | |
| Mayne Pharma Commercial LLC | $25.94 | 2023 | |
| Daiichi Sankyo INC. | $25.90 | 2024 | Injectafer |
| Novo Nordisk INC | $18.55 | 2024 | Wegovy |
| Minerva Surgical, INC | $17.40 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.51 | 2023 | |
| Evofem Biosciences, INC. | $16.51 | 2021 | |
| Convatec INC. | $14.05 | 2024 | |
| Avion Pharmaceuticals | $13.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Kownack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.